Lemyre Madeleine, Bujold Emmanuel, Lathi Ruth, Bhagan Lisa, Huang Jian Qun, Nezhat Camran
Department of Obstetrics and Gynecology, Stanford University Medical Center, Palo Alto CA; Department of Obstetrics and Gynecology, Faculty of Medicine, Laval University, Quebec City QC.
Department of Obstetrics and Gynecology, Faculty of Medicine, Laval University, Quebec City QC.
J Obstet Gynaecol Can. 2012 Jan;34(1):57-62. doi: 10.1016/S1701-2163(16)35134-9.
To compare short-term morbidity and quality of life after laparoscopic hysterectomy (LH) and laparoscopic myomectomy (LM) for the treatment of symptomatic uterine leiomyomas.
We performed a prospective, observational study of women who were eligible for both surgical procedures. After informed consent was obtained, each participant was asked to complete the SF-12v2 Health Survey before surgery and to repeat it seven days and 28 days after surgery. Data on short-term morbidities, such as operative time, blood loss, length of hospital stay, and surgical complications, were collected by an obstetrician-gynaecologist. Women who underwent LH were compared by non-parametric statistical analyses with those who underwent LM.
Sixty-one women were recruited between January 1 and December 31, 2008, including 40 who underwent LM and 21 LH. Women who underwent LH were older, had higher parity, and were less likely to have infertility than those who chose LM. Median LH operative time of 223 minutes (IQR 214 to 241) was slightly longer than for LM (188 minutes, IQR 154 to 239; P = 0.02). However, we found no difference between the two groups in terms of SF-12v2 fluctuation, blood loss, hospital stay, and short-term complications.
Laparoscopic myomectomy is a viable alternative to laparoscopic hysterectomy for women with symptomatic leiomyomas who want conservative surgery. The procedures have similar morbidity and impact on quality of life.
